DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Aktueller Standort:
> This Story

Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment




Cardiology Homepage

The 2019 Heart Rhythm Society scientific sessions: advanced technology in electrophysiology Four key takeaways

New machine learning algorithm could decide who is best for heart failure treatment Could help prevent sudden death from heart failure

Philips teams with Medtronic on cryoablation treatment for atrial fibrillation Will form an integrated solution for cryoablation

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

FDA gives thumbs-up for Biofourmis’ RhythmAnalytics AI Platform Provides automated interpretations of cardiac arrhythmias

Israeli researchers develop first 3D heart from patient's biological materials A first — complete with blood vessels, ventricles and cells

Using comic illustrations to support patient understanding of cardiac catheterization Making patients more satisfied, less anxious and more informed

Medical community finds ways to make TAVR safer for at-risk patients Improving outcomes with special procedures

New ultrasound tech could help detect pediatric congenital heart disease Visualizes structure and blood flow of babies' hearts

Mick Jagger resting after TAVR heart surgery The 75 year old rock star is reportedly recovering from the operation at New York Presbyterian

pacing leads

BIOTRONIK announces availability of smallest MR-conditional pacing leads in U.S.

by Lauren Dubinsky , Senior Reporter
BIOTRONIK announced on Thursday that the smallest MR-conditional pacing lead in the U.S., its Solia S ProMRI, is now commercially available.

The lead received FDA approval on June 9 after its safety and efficacy was demonstrated in the Pre-Market Study phase of the SIELLO clinical study. The study enrolled 1,758 patients at 60 sites in the U.S. and implanted 3,220 Solia leads.

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

After 12 months, 100 percent of those who received an atrial Solia lead were adverse event-free and 99.6 percent who received a ventricular Solia lead were event-free. In addition, for patients with one or two Solia leads there was a 100 percent success rate for sensing and pacing at the 12-month mark.

"As physicians, we're focused on delivering the best possible patient care," Dr. Ulrika Birgersdotter-Green, director of pacemaker and ICD services at UC San Diego Health, told HCB News. "Cardiac innovations that help create a more personalized approach play a critical role in achieving positive outcomes."

The leads are available in three different lengths — 45, 53 and 60 centimeters. According to Birgersdotter-Green, there have been limitations in the lengths of leads available, but since patients have a wide range of anatomy types it’s important to have options.

Solia S ProMRI has a 5.6 French lead body diameter and a polyurethane coating over silicone to limit friction and make it easier for physicians to insert it through small vessels and intricate anatomy. Its soft distal segment is designed to help reduce stress and myocardial trauma.

"Patient anatomy is unique to each and every patient," she said. "For patients with small or complex vessels, complications such as vein occlusion are more likely to occur when using a lead with a wide diameter body. The smaller lead body helps maximize available blood flow and leave room for additional therapies."

BIOTRONIK’s ProMRI technology allows patients with pacemakers, implantable defibrillators, cardiac monitors and cardiac resynchronization therapy defibrillators to undergo an MR scan. According to the company, it has the broadest portfolio of MR-conditional cardiac devices on the market.

Since 2009, almost 600,000 leads in the Solia family have been implanted worldwide.

A couple of the other companies also offer MR-conditional leads. Medtronic’s Specify SureScan MR surgical leads received FDA approval in March, which are used with its spinal cord stimulation system and Boston Scientific’s INGEVITY MRI pacing leads scored approval in April.

Back to HCB News
  Pages: 1

Cardiology Homepage

You Must Be Logged In To Post A Comment

Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Alle Gesundheitsdienstleister-Tools anzeigen
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2019, Inc.